Building on Clarins’ 30-year research portfolio, encompassing 10 patents, 13 peer-reviewed publications, and 12 international academic partnerships, the new center is directed by an international scientific committee chaired by Dr. Olivier Courtin-Clarins.
The center's operational mandate focuses on setting strategic research axes in skin longevity, sponsoring academic doctoral and postdoctoral programs with universities, and publishing empirical findings for both scientific peers and the personal care industry.
Epigenetics and Eight Core Longevity Biomarkers
The center anchors its methodology on epigenetic research demonstrating that while approximately 15% of gene expression is driven by inherited genetics, 85% is modulated by lifestyle, environmental exposure, and daily behavioral choices.
Research streams will directly evaluate the systemic impacts of chronic inflammation, oxidative stress, mitochondrial decline, and impaired cellular repair on skin integrity:
Biomarker Mapping: Identifying and targeting eight primary biomarkers governing skin, scalp, and follicle aging to maintain cellular vitality.
Preventative Formulation Strategy: Transitioning topical development from superficial symptom correction to cellular pathway intervention, continuing the physiological approach introduced with Clarins' 2008 Younger Longer Balm.
Integrative Physiological Models: Modeling skin simultaneously as an environmental barrier, an active immune organ, and a reflection of sleep, nutrition, and metabolic balance.
Dr. Olivier Courtin-Clarins (Chairman of the Scientific Committee, Clarins):
Today the science of longevity allows us to greatly influence the behavior of skin, and I imagine it will undoubtedly reverse it sometime in the future. At Clarins, we focus less on treating the outward signs of ageing but rather center our research on delaying or even reversing age-related behaviors in the skin.
